RxDoctor Payments DataLook up a doctor →

Michele Nobs

Adult Health · Saint Louis, MONPI 1386619138

Payments from drug & device makers

$15,097in general payments, 2019–2025

Across 686 payments — averaging $22.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Seagen Inc.$2K
  • Johnson & Johnson$1K
  • Novartis$973
  • Merck$931
  • Daiichi Sankyo Inc.$740
  • AstraZeneca$598
  • plus $9K from 54 others

What the payments were for

  • Food & beverage$13,76891%
  • Education$1,3299%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Seagen Inc.36$1,535
Johnson & Johnson(2 entities)39$1,006
Novartis55$973
Merck45$931
Daiichi Sankyo Inc.30$740
AstraZeneca(2 entities)30$598
Pfizer32$591
E.r. Squibb & Sons, L.L.C.35$533
EMD Serono, Inc.33$508
Eisai Inc.18$466
Bristol Myers Squibb25$449
AbbVie22$439
Sanofi19$415
Bayer17$398
Incyte Corporation19$385
GSK8$342
Genentech USA, Inc.14$314
Takeda Pharmaceuticals U.S.A., Inc.12$264
Lilly USA, LLC14$262
Exelixis Inc.11$243
Gilead(2 entities)12$221
Regeneron Healthcare Solutions, Inc.9$201
Amgen8$181
Boehringer Ingelheim9$180
Karyopharm Therapeutics Inc.8$176
Beigene USA, Inc.7$157
Jazz Pharmaceuticals Inc.6$151
Tempus AI, Inc4$145
Astellas Pharma US Inc4$144
Taiho Oncology, Inc.8$143
Beone Medicines USA, Inc.6$143
Sobi, Inc6$135
Stemline Therapeutics Inc.6$116
AVEO Pharmaceuticals, Inc.5$106
Array Biopharma Inc6$93
Springworks Therapeutics, Inc.4$90
ADC Therapeutics America, Inc.4$78
Blueprint Medicines Corporation4$78
Dendreon Pharmaceuticals LLC3$76
Servier Pharmaceuticals LLC4$76
Myriad Genetic Laboratories, Inc.3$74
Tersera Therapeutics LLC3$72
Mirati Therapeutics, Inc.3$66
Sumitomo Pharma America, Inc.3$66
Puma Biotechnology, Inc.4$61
Pharmacyclics LLC, An Abbvie Company2$55
Legend Biotech USA Inc.2$53
Morphosys, US Inc.3$51
Rigel Pharmaceuticals, Inc.3$50
Ipsen Biopharmaceuticals, Inc2$50
Geron Corporation2$46
Agios Pharmaceuticals, Inc.2$42
Spectrum Pharmaceuticals Inc.2$35
Azurity Pharmaceuticals, Inc.2$33
Adaptive Biotechnologies Corporation1$27
Recordati_rare_diseases_inc.1$27
Pharmacosmos Therapeutics Inc.1$23
Sun Pharmaceutical Industries Inc.1$22
Immunocore Limited1$22
Pharmaessentia USA Corporation1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,097 in reported general payments places this provider in the 95th percentile of 555 adult health providers in Missouri.

See all adult health providers in Missouri →

Medicare billing

Part B allowed, 2024
$15,438
Medicare patients
130
Services billed
166

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine Hcl ViscousLidocaine Hcl15$335
Letrozole11$58
Potassium Chloride11$36

Paid to pharmacies, not to this prescriber.

Other adult health in Saint Louis

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →